Apple's ResearchKit goes global as heart study expands into Hong Kong and U.K.

Stanford University School of Medicine has expanded its Apple ($AAPL) ResearchKit-based heart health study to Hong Kong and the United Kingdom. The move marks the first time a study run using the ResearchKit platform--which made a splash earlier this year when it facilitated rapid enrollment in a handful of trials--has started accepting participants from outside the U.S. Stanford's study, MyHeart Counts, has enrolled 41,000 people in the U.S., a figure researchers hope to see swell as it expands globally. The team is aiming to go live in other countries in the coming months. Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.